MDM2 Oncoprotein Expression in Soft Tissue Sarcoma
Author Information
Author(s): RAPHAEL E. POLLOCK, AIQUING LANG, ADEL K. EL-NAGGAR, ROBERT RADINSKY, MIEN CHIE HUNG
Primary Institution: MD Anderson Cancer Center, University of Texas
Hypothesis
The study investigates the regulatory mechanisms linking MDM2 DNA amplification to MDM2 oncoprotein over-production in soft tissue sarcoma.
Conclusion
MDM2 oncoprotein over-production in soft tissue sarcomas is associated with various regulatory mechanisms, including DNA amplification and potential post-transcriptional regulation.
Supporting Evidence
- MDM2 DNA amplification was detected in 10 of 30 tumors screened.
- Six specimens provided sufficient biomaterials for further analysis.
- MDM2 oncoprotein over-production was associated with decreased G0/G1 cell cycle arrest.
Takeaway
This study looks at how a protein called MDM2, which can help tumors grow, is made in soft tissue sarcomas and finds that there are different ways it can be produced.
Methodology
The study used a tissue bank of resected soft tissue sarcomas and normal tissues, extracting DNA and RNA for analysis of MDM2 amplification and expression.
Limitations
The study may not account for all possible regulatory mechanisms affecting MDM2 expression.
Want to read the original?
Access the complete publication on the publisher's website